// App-Quantinova.ai

OP0085 (2022) : CELL LINEAGE-SPECIFIC TRANSCRIPT DECONVOLUTION OF SYNOVIAL BIOPSIES FROM THE R4RA TRIAL IDENTIFIES CELL POPULATIONS ASSOCIATED WITH RESPONSE TO RITUXIMAB AND TOCILIZUMAB

Researchers

Presenter

  • F. Rivellese

Principal Investigators

  • C. Cubuk

  • A. Surace

  • K. Goldmann

  • E. Sciacca

  • G. Giorli

  • A. Nerviani

  • L. Fossati-Jimack

  • G. Thorborn

  • M. Bombardieri

  • M. Barnes

  • M. Lewis

  • C. Pitzalis

Medical Centers

  • Queen Mary University of London, Experimental Medicine and Rheumatology, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Tocilizumab

  • Rituximab

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A